TrialJournal for immunotherapy of cancer2019

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study.

Andrea Forschner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.